$0.65
0.0%
Downside
Day's Volatility :12.28%
Upside
12.28%
26.15%
Downside
52 Weeks Volatility :69.43%
Upside
58.6%
Period | Icecure Medical Ltd | Index (Russel 2000) |
---|---|---|
3 Months | 7.24% | 0.0% |
6 Months | -42.71% | 0.0% |
1 Year | -14.91% | 0.0% |
3 Years | -90.48% | -26.0% |
Market Capitalization | 41.1M |
Book Value | $0.21 |
Earnings Per Share (EPS) | -0.29 |
Wall Street Target Price | 3.2 |
Profit Margin | 0.0% |
Operating Margin TTM | -319.29% |
Return On Assets TTM | -47.36% |
Return On Equity TTM | -94.22% |
Revenue TTM | 3.3M |
Revenue Per Share TTM | 0.07 |
Quarterly Revenue Growth YOY | 7.9% |
Gross Profit TTM | 1.4M |
EBITDA | -14.1M |
Diluted Eps TTM | -0.29 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.28 |
EPS Estimate Next Year | -0.25 |
EPS Estimate Current Quarter | -0.07 |
EPS Estimate Next Quarter | -0.07 |
What analysts predicted
Upside of 392.31%
Sell
Neutral
Buy
Icecure Medical Ltd is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Icecure Medical Ltd | 14.56% | -42.71% | -14.91% | -90.48% | -94.01% |
Stryker Corporation | 6.39% | 13.73% | 37.4% | 38.7% | 89.48% |
Boston Scientific Corp. | 2.38% | 19.76% | 71.16% | 107.89% | 119.69% |
Edwards Lifesciences Corp. | -2.97% | -23.63% | 3.15% | -44.24% | -15.34% |
Abbott Laboratories | 0.84% | 11.31% | 24.07% | -8.79% | 39.2% |
Medtronic Plc | -1.27% | 5.89% | 24.11% | -28.34% | -18.75% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Icecure Medical Ltd | NA | NA | NA | -0.28 | -0.94 | -0.47 | NA | 0.21 |
Stryker Corporation | 39.68 | 39.68 | 2.58 | 12.05 | 0.19 | 0.07 | 0.01 | 52.86 |
Boston Scientific Corp. | 71.8 | 71.8 | 1.58 | 2.46 | 0.09 | 0.05 | NA | 14.05 |
Edwards Lifesciences Corp. | 25.57 | 25.57 | 6.04 | 2.53 | 0.19 | 0.11 | NA | 16.18 |
Abbott Laboratories | 35.48 | 35.48 | 2.28 | 4.67 | 0.15 | 0.06 | 0.02 | 22.94 |
Medtronic Plc | 30.24 | 30.24 | 1.66 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Icecure Medical Ltd | Buy | $41.1M | -94.01% | NA | 0.0% |
Stryker Corporation | Buy | $141.0B | 89.48% | 39.68 | 16.34% |
Boston Scientific Corp. | Buy | $128.0B | 119.69% | 71.8 | 11.26% |
Edwards Lifesciences Corp. | Buy | $39.1B | -15.34% | 25.57 | 65.86% |
Abbott Laboratories | Buy | $202.6B | 39.2% | 35.48 | 13.99% |
Medtronic Plc | Buy | $115.6B | -18.75% | 30.24 | 12.06% |
Insights on Icecure Medical Ltd
Revenue is up for the last 2 quarters, 736.35K → 996.84K (in $), with an average increase of 26.1% per quarter
Netprofit is up for the last 2 quarters, -3.57M → -3.03M (in $), with an average increase of 17.7% per quarter
In the last 1 year, Boston Scientific Corp. has given 71.2% return, outperforming this stock by 86.1%
In the last 3 years, Boston Scientific Corp. has given 107.9% return, outperforming this stock by 198.4%
Citadel Advisors Llc
Renaissance Technologies Corp
Virtu Financial LLC
Two Sigma Investments LLC
Foundations Investment Advisors, LLC
Morgan Stanley - Brokerage Accounts
Organization | Icecure Medical Ltd |
Employees | 71 |
CEO | Mr. Eyal Shamir |
Industry | Miscellaneous |
Cactus Acquisition Corp 1 Ltd
$0.65
-11.73%
Rigel Resource Acquisition Corp
$0.65
-11.73%
Fortune Rise Acquisition Corp
$0.65
-11.73%
Canada Goose Holdings Inc.
$0.65
-11.73%
J W Mays Inc
$0.65
-11.73%
American Shared Hospital Services
$0.65
-11.73%
Cambria Shareholder Yield Etf
$0.65
-11.73%
J-long Group Ltd.
$0.65
-11.73%
Cps Technologies Corp
$0.65
-11.73%